Sandeep Laumas, Executive Chairman at INNOVATE BIOPHARMACEUTICALS, INC. (INNT), bought 750 shares at $4.88 ($4K) on 2018-08-28, disclosed to the SEC on 2018-08-28.
Open-market purchase of $4k INNT by Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.88 | 250 | $1K | 32.5% |
| 2 | $5.07 | 95 | $482 | 12.8% |
| 3 | $5.08 | 405 | $2K | 54.7% |
| Total | $5.01 avg | 750 | $4K | 100% |
| Filing → |
| INNT | BUY | 2019-06-17 | $1K | — | Filing → |
| INNT | BUY | 2019-05-23 | $7K | — | Filing → |
| INNT | BUY | 2018-12-03 | $8K | — | Filing → |